Product description
| Symbol | Cusip | Name | Amount | Value | Title Of Class | Pay of profile | |
|---|---|---|---|---|---|---|---|
| N/A | N/A | MIRUM PHARMACEUTICALS, INC. | 152381.0 | 4498287.12 | CORP | Long | |
| N/A | N/A | BETA BIONICS | 482025.81 | 2496893.7 | CORP | Long | |
| 82489T104 | 82489T104 | Shockwave Medical Inc. | 198864.0 | 37895523.84 | CORP | Long | |
| 004225108 | 004225108 | Acadia Pharmaceuticals Inc | 809391.0 | 25342032.21 | CORP | Long | |
| 008064107 | 008064107 | Aerovate Therapeutics Inc | 12178.0 | 275588.14 | CORP | Long | |
| 92337F107 | 92337F107 | Veracyte Inc | 564000.0 | 15515640.0 | CORP | Long | |
| 92243G108 | 92243G108 | Vaxcyte Inc | 607206.0 | 38132536.8 | CORP | Long | |
| 032724106 | 032724106 | AnaptysBio Inc. | 427000.0 | 9146340.0 | CORP | Long | |
| N/A | N/A | METAGENOMI TECHNOLOGIES LLC | 98875.0 | 1390973.5 | CORP | Long | |
| 88322Q108 | 88322Q108 | TG Therapeutics Inc | 439474.0 | 7506215.92 | CORP | Long | |
| 22663K107 | 22663K107 | Crinetics Pharmaceuticals Inc. | 1059633.0 | 37701742.14 | CORP | Long | |
| PPGD27LM5 | PPGD27LM5 | BIOSPLICE THERAPEUTICS INC. SERIES C | 2500000.0 | 2818000.0 | CORP | Long | |
| 46333X108 | 46333X108 | Ironwood Pharmaceuticals, Inc. | 740554.0 | 8471937.76 | CORP | Long | |
| 803607100 | 803607100 | Sarepta Therapeutics Inc | 89219.0 | 8603388.17 | CORP | Long | |
| 705356032 | 705356032 | FLARE THERAPEUTICS INCORPORATED | 902439.0 | 1085634.12 | CORP | Long | |
| 705419577 | 705419577 | CASMA THERAPEUTICS II | 1219013.0 | 364484.89 | CORP | Long | |
| N/A | N/A | BIOSPLICE THERAPEUTICS INC. | 72880.0 | 71422.4 | CORP | Long | |
| 492327101 | 492327101 | Keros Therapeutics Inc. | 580000.0 | 23060800.0 | CORP | Long | |
| 04280A100 | 04280A100 | Arrowhead Pharmaceuticals Inc | 313289.0 | 9586643.4 | CORP | Long | |
| 45790W108 | 45790W108 | Inozyme Pharma Inc | 3179837.0 | 13546105.62 | CORP | Long | |
| 31846V211 | 31846V211 | First American Funds Inc. | 0.21 | 0.21 | RF | Long | |
| N/A | N/A | Korro Bio Inc | 546325.0 | 26185357.25 | CORP | Long | |
| 268158201 | 268158201 | Dynavax Technologies Corp. | 1585771.0 | 22169078.58 | CORP | Long | |
| N/A | N/A | Beta Bionics Series D | 333333.0 | 1346665.32 | CORP | Long | |
| N/A | N/A | CASMA THERAPEUTICS | 5000000.0 | 1495000.0 | CORP | Long | |
| 014MTKKL2 | 014MTKKL2 | METAGENOMI LLC | 686724.0 | 9660833.23 | CORP | Long | |
| 45166A102 | 45166A102 | IDEAYA Biosciences Inc. | 335000.0 | 11919300.0 | CORP | Long | |
| 03969F109 | 03969F109 | Arcus Biosciences Inc. | 240000.0 | 4584000.0 | CORP | Long | |
| 705363656 | 705363656 | CASMA THERAPEUTICS, INC. | 1820413.0 | 544303.49 | CORP | Long | |
| 07373V105 | 07373V105 | Beam Therapeutics Inc. | 261360.0 | 7114219.2 | CORP | Long | |
| 89377M109 | 89377M109 | TransMedics Group Inc. | 214000.0 | 16891020.0 | CORP | Long | |
| 65443P102 | 65443P102 | 908 Devices Inc. | 1430995.0 | 16055763.9 | CORP | Long | |
| 23282W605 | 23282W605 | Cytokinetics Inc | 556000.0 | 46420440.0 | CORP | Long | |
| N/A | N/A | Lexeo Therapeutics Inc | 957377.0 | 12847999.34 | CORP | Long | |
| 45337C102 | 45337C102 | Incyte Corporation. | 121508.0 | 7629487.32 | CORP | Long | |
| G72800108 | G72800108 | Prothena Corporation PLC | 445155.0 | 16176932.7 | CORP | Long | |
| 48576A100 | 48576A100 | Karuna Therapeutics Inc | 190000.0 | 60136900.0 | CORP | Long | |
| 15678U128 | 15678U128 | Cerevel Therapeutics Holdings Inc | 490000.0 | 20776000.0 | CORP | Long | |
| 30063P105 | 30063P105 | Exact Sciences Corporation | 565546.0 | 41839093.08 | CORP | Long | |
| 90400D108 | 90400D108 | Ultragenyx Pharmaceuticals Inc | 359000.0 | 17167380.0 | CORP | Long | |
| 457730109 | 457730109 | Inspire Medical Systems Inc | 125090.0 | 25447058.7 | CORP | Long | |
| 450056106 | 450056106 | Irhythm Technologies Inc | 239135.0 | 25597010.4 | CORP | Long | |
| 04016X101 | 04016X101 | Argenx SE | 88651.0 | 33725499.93 | CORP | Long | |
| G1110E107 | G1110E107 | Biohaven Ltd | 401101.0 | 17167122.8 | CORP | Long | |
| N/A | N/A | GOLDFINCH BIO B2 | 809360.52 | 4394827.62 | CORP | Long | |
| N/A | N/A | CASMA THERAPEUTICS | 5000000.0 | 1495000.0 | CORP | Long | |
| 56854Q200 | 56854Q200 | Marinus Pharmaceuticals Inc | 4529997.0 | 49241067.39 | CORP | Long | |
| 316175108 | 316175108 | Fidelity Institutional Cash Portfolios | 3306956.29 | 3306956.29 | RF | Long | |
| N/A | N/A | GOLDFINCH BIO B2 | 4237288.0 | 0.0 | RF | Long | |
| 705419633 | 705419633 | CASMA THERAPEUTICS II | 1952962.0 | 2349413.29 | RF | Long | |
| 90042W100 | 90042W100 | Turnstone Biologics Corp | 250000.0 | 636250.0 | CORP | Long | |
| 76155X100 | 76155X100 | Revolution Medicines Inc | 361000.0 | 10353480.0 | CORP | Long | |
| 52886X107 | 52886X107 | Lexeo Therapeutics Inc | 2045454.0 | 27449992.68 | CORP | Long | |
| N/A | N/A | FLARE THERAPEUTICS INC | 1097561.0 | 1320365.88 | CORP | Long | |
| 45332Y109 | 45332Y109 | Inari Medical Inc | 512914.0 | 33298376.88 | CORP | Long | |
| 45826J105 | 45826J105 | Intellia Therapeutics Inc | 372665.0 | 11362555.85 | CORP | Long | |
| 05153U107 | 05153U107 | Aura Biosciences Inc. | 5802682.0 | 51411762.52 | CORP | Long | |
| 457669307 | 457669307 | Insmed Inc | 635185.0 | 19684383.15 | CORP | Long | |
| 01J3FSWN4 | 01J3FSWN4 | Beta Bionics Series D | 476190.0 | 2623806.9 | CORP | Long | |
| N/A | N/A | US BANK MMDA | 51802122.51 | 51802122.51 | CORP | Long | |
| N/A | N/A | BIOSPLICE THERAPEUTICS | 295276.0 | 1470474.48 | CORP | Long | |
| N/A | N/A | PROMETHEUS BIOSCIENCES | 1017770.0 | 702261.3 | CORP | Long | |
| N/A | N/A | Avalyn Pharma | 20482289.0 | 14999999.53 | CORP | Long | |
| 03237H101 | 03237H101 | Amylyx Pharmaceuticals Inc | 1116837.0 | 16439840.64 | CORP | Long | |
| 45253H101 | 45253H101 | ImmunoGen, Inc. | 763000.0 | 22622950.0 | CORP | Long | |
| N/A | N/A | SHORELINE BIOSCIENCES | 1489958.0 | 10295609.78 | CORP | Long | |
| 19459J104 | 19459J104 | Collegium Pharmaceutical Inc. | 1285217.0 | 39558979.26 | CORP | Long | |
| 77634L105 | 77634L105 | R1 RCM Inc. | 1375980.0 | 14544108.6 | CORP | Long | |
| 30050B101 | 30050B101 | Evolent Health, Inc. | 1298805.0 | 42899529.15 | CORP | Long | |
| N/A | N/A | BETA BIONIC SERIES B | 940660.91 | 5023129.26 | CORP | Long | |
| 604749101 | 604749101 | Mirum Pharmaceuticals Inc. | 1098318.0 | 32422347.36 | CORP | Long | |
| 19240Q201 | 19240Q201 | Cogent Biosciences Inc. | 2232968.0 | 13129851.84 | CORP | Long | |
| 039697107 | 039697107 | Ardelyx Inc | 4235000.0 | 26257000.0 | CORP | Long | |
| N/A | N/A | BETA BIONICS | 120500.0 | 637445.0 | CORP | Long | |
| 15117B202 | 15117B202 | Celldex Therapeutics Inc. | 1812364.0 | 71878356.24 | CORP | Long | |
| 80706P103 | 80706P103 | Scholar Rock Holding Corp. | 525000.0 | 9870000.0 | CORP | Long | |
| 40131M109 | 40131M109 | Guardant Health Inc | 1168310.0 | 31602785.5 | CORP | Long | |
| 77313F106 | 77313F106 | Rocket Pharmaceuticals Inc | 490732.0 | 14707238.04 | CORP | Long | |
| 98943L107 | 98943L107 | Zentalis Pharmaceuticals Inc | 6581258.0 | 99706058.7 | CORP | Long | |
| 03753U106 | 03753U106 | Apellis Pharmaceuticals Inc | 209794.0 | 12558268.84 | CORP | Long | |
| 501147102 | 501147102 | Krystal Biotech Inc | 136485.0 | 16932329.1 | CORP | Long | |
| 92686J106 | 92686J106 | Viking Therapeutics Inc. | 750000.0 | 13957500.0 | CORP | Long | |
| 02043Q107 | 02043Q107 | Alnylam Pharmaceuticals Inc. | 87000.0 | 16652670.0 | CORP | Long | |
| N/A | N/A | KOJIN THERAPEUTICS | 763319.0 | 467227.56 | CORP | Long | |
| N/A | N/A | GOLDFINCH BIOPHARMA INC | 8474576.0 | 0.0 | CORP | Long | |
| 925050106 | 925050106 | Verona Pharma Plc | 1377781.0 | 27390286.28 | CORP | Long | |
| 10806X102 | 10806X102 | Bridgebio Pharma Inc | 579414.0 | 23390943.18 | CORP | Long | |
| N/A | N/A | PELOTON THERAPEUTICS | 1528871.0 | 1291743.11 | CORP | Long | |
| N/A | N/A | TURNSTONE BIOLOGICS INC | 458317.0 | 1166416.77 | CORP | Long | |
| N/A | N/A | GOLDFINCH BIOPHARMA INC | 5000000.0 | 0.0 | CORP | Long | |
| 09627Y109 | 09627Y109 | Blueprint Medicines Corporation | 312374.0 | 28813377.76 | CORP | Long | |
| N/A | N/A | BRIDGEBIO PHARMA | 137513.0 | 5551399.81 | CORP | Long | |
| G76279101 | G76279101 | Roivant Sciences Ltd | 1143938.0 | 12846423.74 | CORP | Long | |
| N/A | N/A | ARCH ONCOLOGY INC | 4643043.0 | 128798.01 | CORP | Long | |
| N/A | N/A | FREENOME HOLDINGS, INC. | 928098.0 | 6999993.55 | CORP | Long | |
| 74276R102 | 74276R102 | Privia Health Group Inc. | 1000000.0 | 23030000.0 | CORP | Long | |
| 05464T104 | 05464T104 | Axsome Therapeutics Inc. | 346712.0 | 27594808.08 | CORP | Long | |
| 759916109 | 759916109 | Repligen Corporation | 119000.0 | 21396200.0 | CORP | Long | |
| N/A | N/A | KOJIN THERAPEUTICS INC | 763319.0 | 467227.56 | CORP | Long |